Status:
ENROLLING_BY_INVITATION
Optimal Stent Duration After Ureteroscopy
Lead Sponsor:
Mayo Clinic
Conditions:
Ureteral Stent
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
Detailed Description
The rationale for this study is to determine if there is a difference in symptoms or complications among patients undergoing uncomplicated ureteroscopy for stone removal with shorter indwelling stent ...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Participants undergoing unilateral stone treatment. Patients may have stones present bilaterally, but must only be having unilateral intervention.
- The ureteroscopy must be uncomplicated
- Patients undergoing semi-rigid ureteroscopy only, flexible ureteroscopy only, or a combination
- Exclusion Criteria
- Pregnancy
- A stent or nephrostomy tube placed prior to surgery
- Complex ureteroscopy - ureteral injury, ureteral perforation, ureteral stricture, impacted stone
- Infection or struvite stones
- Recurrent Urinary Tract Infection (UTI): 2 culture proven UTI in 6 months or 3 culture proven UTIs in one year
- No stone evident on ureteroscopic evaluation of ureter or kidney
- Transplant kidney
- Variant anatomy (horseshoe, pelvic kidney)
Exclusion
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT06045962
Start Date
November 1 2023
End Date
September 1 2026
Last Update
October 3 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Arizona
Phoenix, Arizona, United States, 85054
2
University of Arizona
Tucson, Arizona, United States, 85712
3
University of California San Diego
San Diego, California, United States, 92122
4
Johns Hopkins University
Baltimore, Maryland, United States, 21206